Agenda

Badge and Materials Pickup

• Shibani Pati MD, PhD
  

  CTTACC Conference Chair
  Professor of Laboratory Medicine, UCSF
  Scientific Director of Cellular Therapies

Discussion will focus upon funding support for the translational pipeline which includes the infrastructure needed for pre-clinical and clinical trials in trauma and critical care. Funding from federal sources, industry, philanthropy and venture capital will be discussed. Panelists will include representation from the NIH, BARDA, DOD, industry stakeholders and a venture capital firm.

• Moderator: Raymond Goodrich PhD
  

  Executive Director, Infectious Disease Research Center
  Office of the Vice President for Research
  Professor, Department of Microbiology, Immunology and Pathology,
  Colorado State University

• Geoffrey Ling MD, PhD
  

  Col, USAF, Ret.
  Chief Executive Officer at SunQ, LLC
  Ex Director of the Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office

• Mary Homer PhD
  

  Chief United States Radiological and Nuclear Countermeasures, Division of Chemical, Biological, Radiological, and Nuclear Countermeasures
  Biomedical Advanced Research and Development Authority (BARDA)

• Michael Davis MD, FACS
  

  Col, USAF
  Director of the US Army Medical Research and Materiel Command’s Combat Casualty Care Research Program (CCCRP)

Discussion will focus upon the translational barriers and challenges that exist in cell product production, development and processing. Panelists will include representation from the private industry, blood banks, NIH and academic centers involved in this space.

• Jonathan Esensten MD, PhD
  

  Medical Director, UCSF HICTF and GMP Facility Medical Director,
  Zuckerberg San Francisco General Hospital Blood Bank and Transfusion
  Service Assistant Adjunct Professor, Dept. of Laboratory Medicine

• Dave Stroncek MD
  

  Chief of Cell Processing
  National Institutes of Health

• Moderator: Kenneth Bertram MD, PhD
  

  Co-Chair CTTACC
  COL, USA, Ret.
  Professor of Regenerative Medicine
  Wakeforest University

• Becky Cap
  

  COO Gencure/BioBridge Global

• Dave Stroncek MD
  

  Chief of Cell Processing
  National Institutes of Health

• Fabio Triolo D.d.R., M.Phil., PhD
  

  Director, Cellular Therapy Core
  Associate Professor Program in Regenerative Medicine
  Department of Pediatric Surgery
  University of Texas Houston

• Jon Rowley PhD
  

  Chief Executive & Technology Officer, RoosterBio, Inc.

• Julie Allickson PhD
  

  Director, Regenerative Medicine Clinical Center
  Wake Forest University School of Medicine

• Robert Mays PhD
  

  Vice President, Regenerative Medicine
  Head of Neurosciences, Athersys, Inc.

Discussion will focus upon the current successes and challenges that exist in finalizing the end of product development which includes optimal cryopreservation, storage, shipping, handling and delivery of the final product to patients. These are areas that are critical for the success and safety of the products, clinical trials and final patient outcomes. Panelists will include representation from the private industry, blood banks and academic centers involved in this space.

• Moderator: Aby J. Mathew PhD
  

  Senior VP & CTO
  BioLife Solutions

• Moderator: Shibani Pati MD, PhD
  

  CTTACC Conference Chair
  Professor of Laboratory Medicine, UCSF
  Scientific Director of Cellular Therapies

• Christopher Murphy
  

  M SGT, USA, Ret.
  CEO Combat Medical Solutions

• David McKenna MD
  

  Professor of Transfusion Medicine
  Director of the Division of Transfusion Medicine
  University of Minnesota

• Donna Chang PhD
  

  President & CEO
  Hope Biosciences

• Fabio Triolo D.d.R., M.Phil., PhD
  

  Director, Cellular Therapy Core
  Associate Professor Program in Regenerative Medicine
  Department of Pediatric Surgery
  University of Texas Houston

• Geoffrey Ling MD, PhD
  

  Col, USAF, Ret.
  Chief Executive Officer at SunQ, LLC
  Ex Director of the Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office

Badge and Materials Pickup

• Shibani Pati MD, PhD
  

  CTTACC Conference Chair
  Professor of Laboratory Medicine, UCSF
  Scientific Director of Cellular Therapies

• Martin Schreiber MD
  

  CTTACC Conference Co-Chair
  COL, USAR
  Professor of Surgery & Chief of Trauma, Critical Care & Acute Care Surgery
  Oregon Health & Science University (OHSU)

• Stacey Shackleford MD
  

  Col, USAF
  Chief, Joint Trauma System Defense Center of Excellence for Trauma
  US Army Institute of Surgical Research

• Jason Sperry MD, MPH
  

  Professor of Surgery and Critical Care
  Director of Acute Care Surgery Fellowship
  University of Pittsburgh

• Moderator: Paul Ness MD
  

  Senior Director, Division of Transfusion Medicine
  Professor of Pathology
  Johns Hopkins University

• Hasan Alam MD
  

  Norman W. Thompson Professor of Surgery
  Section Head of General Surgery
  University of Michigan

• Ernest Moore MD
  

  Professor of Surgery
  Vice Chair of Research
  Editor of Journal of Trauma and Acute Care Surgery

• Martin Schreiber MD
  

  CTTACC Conference Co-Chair
  COL, USAR
  Professor of Surgery & Chief of Trauma, Critical Care & Acute Care Surgery
  Oregon Health & Science University (OHSU)

• Joseph Rappold MD
  

  Co-Chair CTTACC
  CAPT, USN, Ret.
  Professor of Surgery
  Maine Medical Center Tufts University

• Karim Brohi MD
  

  Professor of Trauma Sciences
  Queen Mary University of London
  Director London Major Trauma System

Discussion Panel on Challenges in the Development, Study and Implementation of Pre-hospital Interventions

• Moderator: John Holcomb MD, FACS
  

  Co-Chair CTTACC
  COL, USA, Ret.
  Professor of Surgery
  University of Texas Houston

• Beth Shaz MD
  

  President AABB
  Chief Medical and Scientific Officer
  Senior Vice President at New York Blood Center

• Christophe Martinaud MD
  

  Professor of Transfusion Medicine and Cell Therapy
  French Military Blood Institute Clamart

• Ernest Moore MD
  

  Professor of Surgery
  Vice Chair of Research
  Editor of Journal of Trauma and Acute Care Surgery

• Jason Sperry MD, MPH
  

  Professor of Surgery and Critical Care
  Director of Acute Care Surgery Fellowship
  University of Pittsburgh

• Karim Brohi MD
  

  Professor of Trauma Sciences
  Queen Mary University of London
  Director London Major Trauma System

• Martin Schreiber MD
  

  CTTACC Conference Co-Chair
  COL, USAR
  Professor of Surgery & Chief of Trauma, Critical Care & Acute Care Surgery
  Oregon Health & Science University (OHSU)

• Zafiris Zafirelis
  

  President and CEO, HbO2 Therapeutics LLC

• Rosemary Kozar MD, PhD
  

  Professor of Surgery
  Vice Chair of Research
  University of Maryland

• Larry Corash MD
  

  Senior VP and Chief Scientific Officer Cerus Inc.

• Allan Doctor MD
  

  Professor of Pediatrics, Biochemistry and Bioengineering
  Director, Center for Blood Oxygen Transport and Hemostasis
  University of Maryland School of Medicine

• Beth Shaz MD
  

  President AABB
  Chief Medical and Scientific Officer
  Senior Vice President at New York Blood Center

• Mike Fitzpatrick PhD
  

  COL, USA, Ret.
  President & Director of Research and Development, Cellphire Inc.

• Karim Brohi MD
  

  Professor of Trauma Sciences
  Queen Mary University of London
  Director London Major Trauma System

• Andrew (Andre) Cap MD, PhD
  

  COL, USA
  Associate Professor of Medicine
  Uniformed Services University of the Health Sciences
  Chief, Blood Research Program
  US Army Institute for Surgical Research

• Owen McCarty PhD
  

  Professor and Chair of Department of Biomedical Engineering
  Professor of Department of Cell & Development Biology
  Oregon Health & Science University

• Shibani Pati MD, PhD
  

  CTTACC Conference Chair
  Professor of Laboratory Medicine, UCSF
  Scientific Director of Cellular Therapies

• Alpa Mahuvakar Trivedi PhD
  

  Research Professor
  Department of Laboratory Medicine, UCSF

• Moderator: Lucy Kornblith MD
  

  Assistant Professor of Surgery
  Trauma Surgery and Surgical Critical Care
  University of California San Francisco
  Zuckerberg San Francisco General Hospital

• Moderator: Heather Pidcoke MD PhD
  

  Chief Medical Research Officer
  Associate Director, Research
  Translational Medicine Institute
  Colorado State University

• Michael Davis MD, FACS
  

  Col, USAF
  Director of the US Army Medical Research and Materiel Command’s Combat Casualty Care Research Program (CCCRP)

• Erika Davies PhD
  

  Health Scientist
  Division of Chemical, Biological, Radiological, and Nuclear Countermeasures (DBRN)
  Biomedical Advanced Research and Development Authority (BARDA)

Discussion will focus upon the current successes, challenges and translational barriers that exist in the development of novel blood products. Including dried plasma, dried platelets, dried cryoprecipitate, and more.

• Moderator: Kenneth Bertram MD, PhD
  

  Co-Chair CTTACC
  COL, USA, Ret.
  Professor of Regenerative Medicine
  Wakeforest University

• Moderator: Richard Gonzales MS, MT(ASCP)SBB
  

  COL, USA, Ret.
  President and CEO
  Richblo2d Biologics Consulting Services LLC

• Larry Corash MD
  

  Senior VP and Chief Scientific Officer Cerus Inc.

• Mark Popovsky MD
  

  Chief Medical Officer
  Velico Medical, Inc

• Mike Fitzpatrick PhD
  

  COL, USA, Ret.
  President & Director of Research and Development, Cellphire Inc.

• Peter Marks MD, PhD
  

  Director of the Center for Biologics Evaluation and Research (CBER)
  Food and Drug Administration (FDA)

Badge and Materials Pickup

• David Chang MD, PhD
  

  CEO and President, Allogene Therapeutics Inc.

• Joseph C. Wu MD, PhD
  

  Director, Stanford Cardiovascular Institute Simon H. Stertzer, MD
  Professor of Medicine & Radiology Stanford University School of Medicine

• Clifford Lowell MD, PhD
  

  Professor and Distinguished Chairman Department of Laboratory Medicine, UCSF

• Michael Matthay MD
  

  Professor of Pulmonary Critical Care Medicine
  Associate Director of ICU
  University of California San Francisco

• Robert Mays PhD
  

  Vice President, Regenerative Medicine
  Head of Neurosciences, Athersys, Inc.

• Moderator: Charles Cox MD
  

  Professor of Pediatric Surgery
  Children’s Fund Distinguished Professor
  Center for Stem Cell & Regenerative Medicine
  University of Texas Houston

• Charles Cox MD
  

  Professor of Pediatric Surgery
  Children’s Fund Distinguished Professor
  Center for Stem Cell & Regenerative Medicine
  University of Texas Houston

• Ephron Rosenzweig PhD
  

  Assistant Professor of Neurosciences
  Center for Neural Repair
  University of California San Diego

• Joseph Ciacci MD
  

  Professor of Neurosurgery
  Vice Chair of Research
  University of California San Diego

• Anthony Atala MD
  

  Professor of Surgery
  Chair, Department of Urology
  Director, Wake Forest Institute for Regenerative Medicine at Wake Forest University

• Jan Nolta PhD
  

  Professor and Stem Cell Program Director
  UC Davis Medical Center
  Editor of the Journal – Stem Cells

• Joy Wu MD
  

  Assistant Professor of Medicine
  Co Director Translational Investigator Program
  Stanford University

• Christophe Martinaud MD
  

  Professor of Transfusion Medicine and Cell Therapy
  French Military Blood Institute Clamart

• Jonathan Thon PhD
  

  CEO & Co-Founder at Platelet BioGenesis

• Jürgen Schmitz PhD
  

  Chief Scientific Officer
  Miltenyi Biotec

• Peter Marks MD, PhD
  

  Director of the Center for Biologics Evaluation and Research (CBER)
  Food and Drug Administration (FDA)